AHL
INSM icon

Abel Hall LLC’s Insmed INSM Stock Holding History

Abel Hall LLC’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Sell
2,566
-524
-17% -$63.5K 0.05% 533
2026
Q1 		$505K Buy
3,090
+471
+18% +$72.4K 0.11% 190
2025
Q4 		$456K Buy
2,619
+61
+2% +$11.1K 0.11% 196
2025
Q3 		$368K Sell
2,558
-903
-26% -$111K 0.15% 132
2025
Q2 		$348K Sell
3,461
-810
-19% -$61.9K 0.16% 135
2025
Q1 		$326K Buy
4,271
+938
+28% +$71.8K 0.2% 88
2024
Q4 		$230K Buy
3,333
+151
+5% +$10.9K 0.15% 116
2024
Q3 		$232K Buy
+3,182
New +$235K 0.15% 117

Other funds holding INSM

GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Abel Hall LLC's INSM Position: Q2 2026 in Review

Abel Hall LLC reduced its Insmed (INSM) stake by 17% in Q2 2026, selling an estimated $63.5K and leaving 2,566 shares worth $274K. The position accounts for 0.05% of the portfolio, ranked #533.

Abel Hall LLC first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $505K in Q1 2026. 144 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Abel Hall LLC held 2,566 shares of Insmed worth $274K as of Q2 2026.
  • Abel Hall LLC sold 524 Insmed shares in Q2 2026, an estimated $63.5K.
  • Insmed made up 0.05% of Abel Hall LLC's portfolio in Q2 2026, its #533 holding.
  • Abel Hall LLC first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
  • Abel Hall LLC's Insmed position peaked at $505K in Q1 2026.
  • 144 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.